Durata Therapeutics nets $71.8mm in IPO
Infectious disease-focused start-up Durata Therapeutics Inc. has netted $71.8mm through the sale of 8.6mm common shares (including the overallotment) at $9 each in its initial public offering. Durata had planned to sell 6.25mm common shares priced between $11 and $13.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.